Skip to main content
2024 CNSF Congress Main banner
Neuro|News Annual Edition
Final Program


Calendar-of-Events
Icon Legend
This session is not in your schedule.
This session is in your schedule. Click again to remove it.
Back
Evaluation

Industry Supported Session

Lunch 'n Learn: Neuromuscular Diseases: Differential Diagnosis, Testing Options and reducing the diagnosis odyssey for patients

Thursday, May 23, 2024
12:00 PM – 1:30 PM EST
Location:CF: Ballroom

Audience:

Adult Neurologist, Child Neurologist, Neuroradiologist, Neurophysiologist, Resident, Fellow, Nurses with interest in topic

Learning Level:

Basic (Resident, New Information), Intermediate (Practicing Physician), Advanced (Special Interest, Higher Level Discussion)

Learning Format:

Case studies, Discussion group/peer exchange/user groups, Forum/panels, Lecture/plenary method, Question and answer sessions

CanMEDs Roles:

Medical Expert, Scholar, Collaborator, Leader, Professional

This Lunch and Learn session will provide an in-depth exploration of Neuromuscular Diseases, focusing on the clinical manifestations and differential diagnosis considerations. Participants will learn more about the available testing options including enzymatic assays and genetic testing. This session will highlight the role of Neurologists in recognizing the signs and symptoms of neuromuscular disease, facilitating early diagnosis, and guiding patients to early disease treatment.

The course will provide (1) practical recommendations on the phenotypes of patients who should be considered for genetic testing, (2) some testing options available even to general neurologists, and (3) the value of appropriate diagnosis for the patient and managing neurologist through clinical cases.

This program was developed by the CNSF and Sanofi and was planned to achieve scientific integrity, objectivity and balance. It is an unaccredited learning activity and not eligible for MOC credits.

Learning Objectives:

  • Identify patients who should be screened for genetic forms of neuromuscular disease.
  • Understand the steps and procedures required to access testing options available to neuromuscular specialists and community neurologists (industry sponsored and government funded)
  • Picture patients in their clinical practice who may benefit from gene panel testing.
  • Appreciate the clinical value of accelerating a diagnostic journey for patients and healthcare providers.
  • Recognize the clinical manifestations of Pompe Disease and distinguish them from other neuromuscular diseases.

Presentations:

  • 12:00 PM – 12:05 PM EST
    Welcome & Introductions

    Faculty: Charles Kassardjian

    Faculty: Corey Bacher

  • 12:05 PM – 12:35 PM EST
    Neuromuscular Diseases: Differential Diagnosis, testing options, and reducing the diagnostic odyssey for patients

    Faculty: Charles Kassardjian

  • 12:35 PM – 1:05 PM EST
    Neuromuscular Diseases: Testing Options in the community setting

    Faculty: Corey Bacher

  • 1:05 PM – 1:30 PM EST
    Q&A

    Faculty: Charles Kassardjian

    Faculty: Corey Bacher